Greenlight Biosciences Holdings Top Management
Greenlight Biosciences employs about 10 people. The company is managed by 10 executives with a total tenure of roughly 24 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Analysis of Greenlight Biosciences' management performance can provide insight into the company performance.
Greenlight |
Greenlight Biosciences Management Team Effectiveness
The company has return on total asset (ROA) of (0.8178) % which means that it has lost $0.8178 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.6687) %, meaning that it created substantial loss on money invested by shareholders. Greenlight Biosciences' management efficiency ratios could be used to measure how well Greenlight Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.Greenlight Biosciences Workforce Comparison
Greenlight Biosciences Holdings is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 358. Greenlight Biosciences holds roughly 10.0 in number of employees claiming about 2.79% of equities under Health Care industry.
Greenlight Biosciences Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Greenlight Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Greenlight Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Greenlight Biosciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Lewis Clark Plant Sciences Fund I Lp over a year ago Acquisition or disposition of Greenlight Biosciences securities by Lewis Clark Plant Sciences Fund I Lp | ||
Morningside Venture Investments Ltd over a year ago Acquisition or disposition of Greenlight Biosciences securities by Morningside Venture Investments Ltd | ||
New Stuff Deux Llc over a year ago Acquisition or disposition of Greenlight Biosciences securities by New Stuff Deux Llc | ||
Fall Line Endurance Fund Lp over a year ago Greenlight Biosciences exotic insider transaction detected | ||
Lurantos Maria Helena over a year ago Greenlight Biosciences exotic insider transaction detected | ||
Xeraya Cove Ltd over a year ago Greenlight Biosciences exotic insider transaction detected | ||
Chelt Trading Ltd over a year ago Greenlight Biosciences exotic insider transaction detected | ||
Continental Grain Co over a year ago Greenlight Biosciences exotic insider transaction detected |
Greenlight Biosciences Notable Stakeholders
A Greenlight Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Greenlight Biosciences often face trade-offs trying to please all of them. Greenlight Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Greenlight Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Susan MBA | CFO Officer | Profile | |
| Mark Singleton | Chief Health | Profile | |
| Charu MBA | Chief Officer | Profile | |
| Amin Khan | Chief Health | Profile | |
| Drew Cunningham | Chief Officer | Profile | |
| Thomas Crampton | Sr Affairs | Profile | |
| Andrey Zarur | President, CoFounder | Profile | |
| Carole MBA | Chief Officer | Profile | |
| David Esq | Gen Sec | Profile | |
| MSc MBA | CoFounder Health | Profile |
Greenlight Biosciences Workforce Analysis
Traditionally, organizations such as Greenlight Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Greenlight Biosciences within its industry.Greenlight Biosciences Manpower Efficiency
Return on Greenlight Biosciences Manpower
| Revenue Per Employee | 638.4K | |
| Revenue Per Executive | 638.4K | |
| Net Loss Per Employee | 16.7M | |
| Net Loss Per Executive | 16.7M | |
| Working Capital Per Employee | 3.6M | |
| Working Capital Per Executive | 3.6M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Greenlight Stock
If you are still planning to invest in Greenlight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Greenlight Biosciences' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |